Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 9, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 10, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001225208-26-006578
Filed / recorded
Jul 10, 2026, 9:11 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Edwards Lifesciences Corp
Issuer CIK
1099800
Ticker
EW
Reporting person
Theodora Mistras
Relationship
Officer
Officer title
CVP, Chief Financial Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Jul 9, 2026
Transaction code
A
Shares / units
87,595
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
87,595
Ownership form
Direct
Amendment
No
Footnotes from the filing
These restricted stock units were granted on July 9, 2026, under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest as follows: 43.75% on the first anniversary of May 29, 2026 (the "Start Date"), 50% on the second anniversary of the Start Date, and the remaining 6.25% on the third anniversary of the Start Date.